News

Do you live with eczema? Offer your perspective in this online survey

New research undertaken by Monash University seeks to understand the psychosocial burden of atopic dermatitis (commonly known as eczema) and how this varies between Australians living in regional and urban areas.

If you’re interested in participating in clinical research trials, consider registering your details with the Allergy and Immunology Research Unit (AIRU)’s new Allergy Research Registry South Australia.

If you’re interested in participating in clinical research trials, consider registering your details with the Allergy and Immunology Research Unit (AIRU)’s new Allergy Research Registry South Australia.

If you’re interested in participating in clinical research trials, consider registering your details with the Allergy and Immunology Research Unit (AIRU)’s new Allergy Research Registry South Australia.

The adrenaline device Jext® is coming soon to Australia. 

If you’re interested in participating in clinical research trials, consider registering your details with the Allergy and Immunology Research Unit (AIRU)’s new Allergy Research Registry South Australia.

The adrenaline device neffy®, a needle-free nasal spray, is planned to be launched in Australia in the first quarter of 2026. 

This project focused on capturing views of people with allergic rhinitis, often called hay fever…

National patient support organisation and registered charity Allergy & Anaphylaxis Australia welcomes a new CEO, following an extensive search…

Allergy & Anaphylaxis Australia invites you to read our Impact Report for 2025.

The adrenaline device, neffy® is a needle-free nasal spray which has been approved for use for the treatment of anaphylaxis in both Europe and US.

The National Allergy Council is holding an Allergy 250k young adult camp this November.